ID: 129935413 | ATAC-STARR-seq lymphoblastoid active region 16990 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201363867..201363916) | | |
ID: 129935412 | ATAC-STARR-seq lymphoblastoid active region 16989 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201258421..201258840) | | |
ID: 129935411 | ATAC-STARR-seq lymphoblastoid active region 16988 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201258341..201258400) | | |
ID: 129935410 | ATAC-STARR-seq lymphoblastoid active region 16986 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201257581..201257630) | | |
ID: 129935409 | ATAC-STARR-seq lymphoblastoid active region 16985 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201248353..201248412) | | |
ID: 129935408 | ATAC-STARR-seq lymphoblastoid active region 16984 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201234532..201234651) | | |
ID: 129935407 | ATAC-STARR-seq lymphoblastoid active region 16983 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201232185..201232434) | | |
ID: 129935406 | ATAC-STARR-seq lymphoblastoid active region 16982 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201223252..201223521) | | |
ID: 129935405 | ATAC-STARR-seq lymphoblastoid active region 16981 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201208985..201209034) | | |
ID: 129935404 | ATAC-STARR-seq lymphoblastoid active region 16980 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201158191..201158520) | | |
ID: 129935403 | ATAC-STARR-seq lymphoblastoid active region 16979 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201158091..201158170) | | |
ID: 128772256 | melanoma risk locus-associated MPRA allelic enhancer 2:202153225 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201288430..201288574) | | |
ID: 128772255 | melanoma risk locus-associated MPRA allelic enhancer 2:202122995 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201258111..201258344) | | |
ID: 127275535 | H3K4me1 hESC enhancer GRCh37_chr2:202185185-202185684 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201320462..201320961) | | |
ID: 127275534 | H3K4me1 hESC enhancer GRCh37_chr2:202184683-202185184 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201319960..201320461) | | |
ID: 127275533 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr2:202084159-202084703 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201219436..201219980) | | |
ID: 127275532 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr2:202014382-202015067 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201149659..201150344) | | |
ID: 126806471 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr2:202015298-202016497 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201150575..201151774) | | |
ID: 122861277 | Sharpr-MPRA regulatory region 10379 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201149166..201149460) | | |
ID: 107075100 | MT-ND4L pseudogene 13 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (201214653..201214950, complement) | | |